BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Deibert P, Lazaro A, Schaffner D, Berg A, Koenig D, Kreisel W, Baumstark MW, Steinmann D, Buechert M, Lange T. Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. World J Gastroenterol 2019; 25(9): 1116-1131 [PMID: 30862999 DOI: 10.3748/wjg.v25.i9.1116]
URL: https://www.wjgnet.com/1007-9327/full/v25/i9/1116.htm
Number Citing Articles
1
Menooa Ebrahimi, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, Soghra Rabizadeh, Mojdeh Sarzaeim, Amirhossein Yadegar, Fatemeh Mohammadi, Razman Arabzadeh Bahri, Peyman Pakravan, Paria Shafiekhani, Manouchehr Nakhjavani, Alireza Esteghamati. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysisLipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01802-6
2
Sayma Yaqub, Patricia Ananias, Arpita Shah, Kanita Luenam, Arunima Mariya Jose, Joao Pedro Melo, Arifa Turkistani, Lubna Mohammed. Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic ReviewCureus 2021;  doi: 10.7759/cureus.18201
3
Margaret Spinosa, She-Yan Wong. Screening for Non-alcoholic Fatty Liver Disease in Current PracticeCurrent Hepatology Reports 2021; 20(4): 128 doi: 10.1007/s11901-021-00577-7
4
Mathilde Simonson, Yves Boirie, Christelle Guillet. Protein, amino acids and obesity treatmentReviews in Endocrine and Metabolic Disorders 2020; 21(3): 341 doi: 10.1007/s11154-020-09574-5
5
Scott A. Willis, Stephen J. Bawden, Sundus Malaikah, Jack A. Sargeant, David J. Stensel, Guruprasad P. Aithal, James A. King. The role of hepatic lipid composition in obesity‐related metabolic diseaseLiver International 2021; 41(12): 2819 doi: 10.1111/liv.15059
6
V. H. Nguyen, Y. H. Yeo, B. Zou, M. H. Le, L. Henry, R. C. Cheung, M. H. Nguyen. Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLDJournal of Internal Medicine 2021; 289(6): 840 doi: 10.1111/joim.13203
7
Huda M El-Sayed, Zeinab H El-Sayd, Tarek G Megahed, Mohammed M. Abd El-Wahab H El-Nabi. Fetuin-AThe Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(2): 446 doi: 10.4103/sjamf.sjamf_53_19
8
Aloys Berg, H. David McCarthy. A soy-yoghurt-honey product as a therapeutic functional food: mode of action and narrative reviewHeliyon 2022; 8(11): e11011 doi: 10.1016/j.heliyon.2022.e11011
9
Elke Roeb. MASLD – Prävention und ernährungsmedizinische BehandlungsmöglichkeitenAktuelle Ernährungsmedizin 2023; 48(05): 362 doi: 10.1055/a-2145-0934
10
Scott A. Willis, Sundus Malaikah, Siôn Parry, Stephen Bawden, Gaël Ennequin, Jack A. Sargeant, Thomas Yates, David R. Webb, Melanie J. Davies, David J. Stensel, Guruprasad P. Aithal, James A. King. The effect of acute and chronic exercise on hepatic lipid compositionScandinavian Journal of Medicine & Science in Sports 2023; 33(5): 550 doi: 10.1111/sms.14310
11
Vera Francisco, Maria Jesus Sanz, José T. Real, Patrice Marques, Maurizio Capuozzo, Djedjiga Ait Eldjoudi, Oreste Gualillo. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?Biology 2022; 11(8): 1237 doi: 10.3390/biology11081237
12
Johanna K. DiStefano. The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal WomenNutrients 2023; 15(12): 2670 doi: 10.3390/nu15122670
13
Asal Neshatbini Tehrani, Behzad Hatami, Bizhan Helli, Zahra Yari, Ghazal Daftari, Amin Salehpour, Mehdi Hedayati, Elmira Khalili, Seyed Ahmad Hosseini, Azita Hekmatdoost. The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin AScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55747-6
14
Peng Ma, Hao Ou, Zhongkan Sun, Yunbiao Lu, Mengdan Li, Liuxin Xu, Yan Liang, Jiawei Zheng, Yu Ou. IAVPGEVA: Orally Available DPP4-Targeting Soy Glycinin Derived Octapeptide with Therapeutic Potential in Nonalcoholic SteatohepatitisJournal of Agricultural and Food Chemistry 2024; 72(13): 7167 doi: 10.1021/acs.jafc.3c08932
15
Eunbyul Cho, Sunwoo Kim, Soonkyu Kim, Ju Young Kim, Hwa Jung Kim, Yumi Go, Yu Jung Lee, Haesol Lee, Siye Gil, Sung Kwon Yoon, Keonho Chu. The Effect of Mobile Lifestyle Intervention Combined with High-Protein Meal Replacement on Liver Function in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Controlled TrialNutrients 2024; 16(14): 2254 doi: 10.3390/nu16142254
16
Pian Xiong, Yong-Fen Zhu. Soy diet for nonalcoholic fatty liver diseaseMedicine 2021; 100(22): e25817 doi: 10.1097/MD.0000000000025817
17
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz, F. Tacke. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025Zeitschrift für Gastroenterologie 2022; 60(09): 1346 doi: 10.1055/a-1880-2283
18
Ingrid Rivera-Iñiguez, Arturo Panduro, Sonia Roman, Karina González-Aldaco. What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?Annals of Hepatology 2023; 28(1): 100874 doi: 10.1016/j.aohep.2022.100874
19
Somaye Fatahi, Danial Fotros, Mohammad Hassan Sohouli, Koroush Vahidshahi, Pejman Rohani, Nathalia Sernizon Guimarães. Meal replacements on obesity and leptin: a systematic review and meta-analysisReviews in Endocrine and Metabolic Disorders 2024;  doi: 10.1007/s11154-024-09918-5
20
Elke Roeb. NAFLD – Prävention und ernährungsmedizinische BehandlungsmöglichkeitenErnährung & Medizin 2022; 37(04): 167 doi: 10.1055/a-1917-8335
21
Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025Zeitschrift für Gastroenterologie 2022; 60(09): e733 doi: 10.1055/a-1880-2388
22
Pernilla Peterson, Lena Trinh, Sven Månsson. Quantitative 1H MRI and MRS of fatty acid compositionMagnetic Resonance in Medicine 2021; 85(1): 49 doi: 10.1002/mrm.28471
23
Chao-Wu Xiao, Amy Hendry. Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A ReviewPlant Foods for Human Nutrition 2022; 77(3): 319 doi: 10.1007/s11130-022-00984-1
24
Hong Pan, Baocheng Liu, Xin Luo, Xinxin Shen, Jijia Sun, An Zhang. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional studyLipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01966-1
25
Daisuke Yoshimaru. 6. Methods of Abdominal MR Spectroscopy and Future ProspectsJapanese Journal of Radiological Technology 2022; 78(2): 213 doi: 10.6009/jjrt.780214
26
Fang-Zhou Ye, Wen-Yue Liu, Kenneth I. Zheng, Xiao-Yan Pan, Hong-Lei Ma, Xiao-Dong Wang, Yong-Ping Chen, Ming-Hua Zheng. Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2020; 32(1): 80 doi: 10.1097/MEG.0000000000001483
27
Lei Ai, Wei Luo, Peng Yuan, Ling Liu, Yue Zhou. Liver macrophages mediate effects of downhill running and caloric restriction on nonalcoholic fatty liver disease of high fat diet-fed miceLife Sciences 2020; 256: 117978 doi: 10.1016/j.lfs.2020.117978
28
Scott A. Willis, Sundus Malaikah, Stephen J. Bawden, Aron P. Sherry, Jack A. Sargeant, Nicole A. Coull, Christopher R. Bradley, Alex Rowlands, Iyad Naim, Gaël Ennequin, Thomas Yates, Ghazala Waheed, Penny Gowland, David J. Stensel, David R. Webb, Melanie J. Davies, Guruprasad P. Aithal, James A. King. Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise trainingDiabetes, Obesity and Metabolism 2024; 26(9): 4030 doi: 10.1111/dom.15755
29
Daniel de Luis, David Primo, Olatz Izaola, Juan Jose Lopez. Effects of a Short-Term Meal Replacement Hypocaloric Diet in Subjects with Obesity and High Fatty Liver IndexNutrients 2022; 14(24): 5353 doi: 10.3390/nu14245353
30
Xiao-Ni Chai, Bing-Qian Zhou, Ni Ning, Ting Pan, Fan Xu, Si-Han He, Ni-Ni Chen, Mei Sun. Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysisFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1081096
31
Martin Buechert, Thomas Lange, Peter Deibert, Paul Urbain. In Vivo Fat Quantification: Monitoring Effects of a 6-Week Non-Energy-Restricted Ketogenic Diet in Healthy Adults Using MRI, ADP and BIANutrients 2020; 12(1): 244 doi: 10.3390/nu12010244
32
Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, Michaela Noreik, Elizabeth Morris, Indrani Manoharan, Kate Tudor, Emma Bodenham, Anna Dunnigan, Susan A. Jebb, Paul Aveyard. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysisMetabolism 2021; 115: 154455 doi: 10.1016/j.metabol.2020.154455
33
Christine L. Freer, Elena S. George, Sze-Yen Tan, Gavin Abbott, Robin M. Daly. Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trialBritish Journal of Nutrition 2024; : 1 doi: 10.1017/S0007114524000242